Synthego Corporation is a biotechnology company that specializes in enabling life science research and development with a focus on improving human health through CRISPR-based technology. The company offers a range of solutions and expertise designed to advance CRISPR therapeutics, facilitating research and early-stage development up to clinical trials. Synthego provides products such as RNA enzymes and CRISPR nucleases, as well as services for regulatory support and off-target analysis, supporting the development of gene and cell therapies.